Abstract 3129: BYON4413, an in vivo active CD123-targeting antibody-drug conjugate, combines effectively with azacitidine and venetoclax in acute myeloid leukemia cell lines
van der Lee, Miranda M.C., van Achterberg, Tanja, Hersmus, Kaylee, Brouwers-Vos, Annet, van der Vleuten, Monique, Pruis, Maurien, Kappers, Wendy, Verheijden, Gijs, Huls, Gerwin, van Wigcheren, Glenn, Ubink, Ruud, Sesink, Aloys, MacInnes, Alyson, Schuringa, Jan Jacob, Dokter, Wim
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article